Weight Loss Treatments and Plans

Weight Loss Treatments

At Rowlands, we currently offer a variety of treatment options to eligible customers. Your pharmacist will discuss your treatment options to ensure you make the best decision for your weight loss journey.

Prescription treatment options overview

Mounjaro

Mounjaro

Weekly injection

Active ingredient: Tirzepatide

From £169.99 per month

Potential to lose up to 20% of your body weight in 72 weeks [1]

Wegovy

Wegovy

Weekly injection

Active ingredient: Semaglutide

From £99.99 per month

Potential to lose 15% of your body weight in 68 weeks [2]

Liraglutide

Liraglutide

Daily injection

Active ingredient: Liraglutide

From £99.99 per month

Potential for at least a 5% reduction in initial body weight after 12 weeks on 3.0mg per day [3]

Wegovy (Tablet)

Wegovy (Tablet)

Daily tablet

Active ingredient: Semaglutide

From £99.99 per month

Up to 16.6% after 64 weeks at 25mg for early responders [4]

Frequently Asked Questions

See the below treatment information pages for the latest treatment cost

The weight loss treatment that works best for you depends on your preferences. All of the treatment optionsare effective and safe choices if you need an extra boost to help you reach your health goals.

The best weight loss injection for you depends on your circumstances. You and your pharmacist will discuss the treatment options in detail to allow you to come to a confident conclusion.

MounjaroWegovy, and Liraglutide offer effective weight loss potential and are available as a prescription if your BMI is:

  • 30 kg/m2 or more (obese)
  • 27 kg/m2 or more (overweight) and you also have a weight-related medical condition, such as prediabetes or high blood pressure (hypertension)

Yes, our weight loss injections have been tested to ensure their safety. During our initial consultation, you’ll receive professional advice and guidance to ensure that your pharmacist has all the information they need to provide the correct treatment and that you are confident enough to begin treatment.

All the information you need to follow during your treatment is available on our website, and your pharmacist is always on hand to offer support. Plus, with regular check-ins, your pharmacist will be able to monitor your progress to ensure the treatment is working as it should, and you can report any side effects that you may be experiencing.

Yes, our weight loss tablets have been tested to ensure their safety. During our initial consultation, you’ll receive professional advice and guidance to ensure that your pharmacist has all the information they need to provide the correct treatment and that you are confident enough to begin treatment.

You can find out more about weight loss tablets here.

Yes, Mounjaro, Wegovy, and Liraglutide are all proven effective weight-loss treatments.

  • Clinical trials have shown that 96% of patients using Mounjaro have successfully shed at least 5% of their body weight, surpassing those who relied solely on diet and exercise. [1]
  • In a 68-week study involving 1,961 adults struggling with obesity or related health issues, participants lost about 15% of their weight with Wegovy. [2]
  • When using Liraglutide, patients have the potential for at least a 5% reduction in initial body weight after 12 weeks on 3.0mg per day [4]

Yes, the Wegovy weight loss tablets have proven to safely help patients lose at least 5% of their body weight after 12 weeks [3]

Our weekly weight-loss injections are self-administered into your thigh, upper arm, or abdomen. By targeting specific receptors in the brain, our weight-loss injections help you feel fuller for longer and reduce cravings. They do not dissolve body fat.

Combining your weight loss injection with a balanced diet and regular exercise, you will see long-term results and reach your health goals.

This guide aims to clearly understand what to expect when beginning treatment with either Mounjaro or Wegovy.

Read our week-by-week guide

Sources
[1] https://clinicaltrials.gov/
[2] https://www.wegovy.co.uk/
[3] https://www.nejm.org/
[4] https://ml-eu.globenewswire.com/